期刊
NEOPLASIA
卷 12, 期 7, 页码 590-U95出版社
ELSEVIER SCIENCE INC
DOI: 10.1593/neo.10726
关键词
-
类别
资金
- National Cancer Institute (NCI) [CA125612]
- Early Detection Research Network [U01CA111275-06]
- Prostate Cancer Foundation [P50CA69568, R01CA132874]
- Doris Duke Charitable Foundation
- Burroughs Welcome Foundation
- Dana-Farber Harvard Cancer Center
TMPRSS2-ERG gene fusions occur in 50% of prostate cancers and result in the overexpression of a chimeric fusion transcript that encodes a truncated ERG product. Previous attempts to detect truncated ERG products have been hindered by a lack of specific antibodies. Here, we characterize a rabbit anti-ERG monoclonal antibody (clone EPR 3864; Epitomics, Burlingame, CA) using immunoblot analysis on prostate cancer cell lines, synthetic TMPRSS2-ERG constructs, chromatin immunoprecipitation, and immunofluorescence. We correlated ERG protein expression with the presence of ERG gene rearrangements in prostate cancer tissues using a combined immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) analysis. We independently evaluated two patient cohorts and observed
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据